The News
Novo Nordisk said it would slash the price of its blockbuster weight-loss drug Wegovy in the US and sell it directly to patients.
The decision forms part of efforts to beat back growing competition in the sector, which also includes competitors Mounjaro and Ozempic.
Millions…